Alzex Neuropharma Inc.
TRRI
$0.10
-$0.02-16.67%
| 06/30/2011 | 03/31/2011 | 09/30/2010 | 06/30/2010 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1,311.11% | -71.22% | -2.70% | -81.40% | |
| Total Receivables | -53.87% | -45.38% | -35.43% | -29.74% | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 216.00% | -20.09% | -20.00% | 0.00% | |
| Total Current Assets | -29.98% | -46.87% | -34.81% | -32.50% | |
|
|
|||||
| Total Current Assets | -29.98% | -46.87% | -34.81% | -32.50% | |
| Net Property, Plant & Equipment | -- | -94.33% | -65.09% | -58.02% | |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | |
| Total Other Intangibles | -32.50% | -36.31% | -11.43% | -8.19% | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | 258.86% | 723.47% | -5.39% | |
| Total Assets | -13.51% | -11.19% | 12.18% | -8.40% | |
|
|
|||||
| Total Accounts Payable | 36.96% | -93.96% | -71.72% | -23.92% | |
| Total Accrued Expenses | 703.54% | 204.76% | 182.22% | -83.41% | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | -33.77% | -- | -87.49% | -74.92% | |
| Total Other Current Liabilities | -33.77% | -- | -87.49% | -74.92% | |
| Total Current Liabilities | 87.36% | -60.17% | -76.17% | -61.05% | |
|
|
|||||
| Total Current Liabilities | 87.36% | -60.17% | -76.17% | -61.05% | |
| Long-Term Debt | -42.46% | -28.97% | -15.05% | -9.95% | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | -33.34% | -35.35% | -27.01% | -16.85% | |
|
|
|||||
| Common Stock & APIC | 6.48% | 23.09% | 479.39% | 269.06% | |
| Retained Earnings | 35.29% | 27.61% | 71.46% | 70.67% | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 24.04% | 41.32% | 254.19% | 195.44% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | 0.00% | 0.00% | 0.00% | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | 0.00% | -99.30% | -99.30% | |
|
|
|||||
| Total Common Equity | 24.04% | 41.32% | 254.19% | 195.44% | |
| Total Preferred Equity | -- | 0.00% | -99.30% | -99.30% | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 22.36% | 40.78% | 127.89% | 12.21% | |
|
|
|||||
